IMPORTANCE Surgery represents the mainstay treatment of colorectal liver metastases. Indications for the laparoscopic approach in this setting have been widened and there is a need to confirm the benefits of minimally invasive liver surgery (MILS) in patients with complex disease states.
T he only treatment with potentially curative intent for patients affected by colorectal liver metastases (CLMs) is liver resection. Oncologic and surgical advances, together with the implementation of the concept of multidisciplinary management, 1 have allowed for a significant expansion of potential candidates for resection, maintaining an adequate profile of safety, and for the recent allocation of a higher proportion of patients able to undergo surgery with minimally invasive techniques. 2 Benefits of the laparoscopic approach have been documented with a high degree of evidence by retrospective comparative studies, meta-analyses, and, more recently, results from the Oslo-CoMet (Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study) trial that concluded that, in laparoscopic parenchymal-sparing resections, the rate of morbidity was reduced while oncologic adequacy was comparable to that seen with open surgical techniques 3 ; currently,
CLMs constitute one of the most frequent diagnoses in laparoscopic series. Despite this fact, different policies for selecting patients for laparoscopy or open surgery have hindered the reliability and clinical applicability of the results of many retrospective studies; more complex and challenging cases were not considered for the laparoscopic technique in the past, especially in series including the first selected cases of limited metastatic disease. [4] [5] [6] [7] Determining the effect of the recent shift toward minimally invasive surgery by analyzing the ratio between laparoscopic surgery and open surgery for liver resections in highvolume institutions has never been specifically addressed in terms of short-term and long-term postoperative outcomes for patients with metastases. To our knowledge, there is no evidence in the literature describing how minimally invasive surgery manages to be representative of the whole group of patients with CLMs (especially in terms of disease burden, damage of liver parenchyma because of previous chemotherapy, and overall surgical complexity). Furthermore, wider recruitment of patients for minimally invasive surgery can help determine short-term outcomes and, therefore, jeopardize the favorable results of laparoscopy.
In the present study, patients with CLMs who underwent laparoscopic surgery and patients with CLMs who underwent open surgery were compared after application of propensity score matching to the most recent laparoscopic series (ie, when, owing to wider indications and accomplishment of the learning curve, the proportion of minimally invasive cases were significantly increased). Our primary aim was to compare intraoperative and postoperative outcomes of patients, especially in terms of morbidity, mortality, functional recovery, and the interval between surgery and adjuvant treatments. Secondary end points were long-term outcomes.
Methods

Study Design
A total of 2418 hepatic resections were performed at the Hepatobiliary Surgery Division of San Raffaele Hospital, Milano, Italy, between January 1, 2004, and June 30, 2017. During the study period, 885 resections for CLMs (36.6%) were performed; of these, 187 were performed using the minimally invasive liver surgery (MILS) approach, constituting the study group, and 698 were performed using the open approach, constituting the control group (Figure 1) . The inclusion trend of liver resections to either the MILS group or the open group was observed during the study period, and the ratio of MILS to total resections for CLMs was calculated per year. Approval to perform this retrospective study was obtained from the Institutional Review Board of San Raffaele Hospital, Milano, and written informed consent was obtained from the participants.
Time-dependent propensity score matching was used to compare the 2 groups; only procedures performed using the MILS approach with a ratio of MILS to total resections per year of more than 30% were considered and were matched to procedures performed using the open approach with a ratio of MILS to total resections per year of less than 30%. group, for a ratio of 1:4). Patient age, American Society of Anesthesiology score, number of chemotherapy cycles, primary tumor location and staging, number of liver lesions, and type of hepatectomy were used as covariates to achieve the propensity score matching.
Preoperative Workup
The indication for surgery and the characteristics (type and approach) of liver resections were discussed for every patient during weekly multidisciplinary tumor boards, with the participation of liver surgeons, radiologists, and medical oncologists. Indications for preoperative chemotherapy were initially unresectable liver metastases, until conversion to resectability, and borderline or easily resectable liver disease with neoadjuvant intent, unless none or only 1 of the following was detected: synchronous presentation, primary tumor nodal involvement, multiple liver metastases, carcinoembryonic antigen level higher than 200 ng/mL (to convert to micrograms per liter, multiply by 1.0), and metastases with a diameter larger than 5 cm.
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Procedures
For open procedures, right J-shaped incisions were performed. Features of lesions (number, size, and relationship with liver vascular structures) were assessed by intraoperative ultrasonography. As far as technically possible, primary vascular control of inflow was achieved before parenchymal transection, while vascular control of outflow was obtained transparenchymally. Technological ultrasonic-mediated dissection was used to perform parenchymal transection. For laparoscopic resections, the French position was used to place the patient; the patient's legs were apart with the first surgeon standing between the legs and 1 assistant on each side. 10 Intraoperative ultrasonography was routinely performed, with the same end points as for the open procedures. Hepatic transection was performed using the SonoSurg system (Olympus). Vessels were coagulated or clipped or stapled according to their size. The Pringle maneuver was used systematically to control intraoperative bleeding.
Variables
The difficulty score of Ban et al, 11 developed in the setting of laparoscopic resections and considering 5 preoperative factors (tumor location, extent of liver resection, tumor size, proximity to major vessels, and liver function), was calculated for every patient. Intraoperative and postoperative outcomes were evaluated, including morbidity and mortality. Postoperative complications were reviewed for 90 days after liver resection; the Dindo-Clavien classification of surgical complications was used to grade them. 12 Time for functional recovery and length of stay were considered. The interval between surgery and resumption of chemotherapy was also calculated. Data regarding follow-up, including survival status, incidence, and type of recurrence, were recorded. Threeyear and 5-year overall survival and disease-free survival were evaluated using the Kaplan-Meier method.
Statistical Analysis
Patients in the MILS group were selected according to propensity scores based on the covariates already mentioned in a ratio of 1:4 and were then matched to patients in the open surgery group. After matching, the χ 2 or Fisher exact test for categorical data, the Mann-Whitney test for nonnormally distributed continuous data, and the t test for normally distributed continuous variables were used for comparison. All data were expressed as mean (SD) or median (range) values, as appropriate. Survival curves were generated and compared using the Kaplan-Meier method. Statistical significance was defined as P < .05 (2-sided). All analyses were performed using the statistical package SPSS, version 18.0 (SPSS Inc). 
Results
Participants
Short-term Outcomes: Primary End Point
As shown in Table 1 , propensity score matching allowed us to obtain similar groups in terms of preoperative characteristics. The median difficulty score was 6 (range, 2-10) in the MILS group and 7 (range, 2-10) in the open group (P =.12)( Table 2 ). The difficulty score is based on the following 5 factors, obtained from preoperative information: tumor location, extent of liver resection, tumor size, proximity to major vessels, and liver function. The difficulty index was determined by the total score derived by the scores for the 5 factors. Based on the final score, each procedure can then classified into 3 different categories: low difficulty (score, Table 3) . 
Long-term Outcome: Secondary End Points
Long-term outcomes of overall and disease-free survival are represented in Figure 2A 
Discussion
The present study reports a single institution's experience with patients affected by CLMs, treated during a 14-year time period. Previous series from the literature 5,6,13 revealed the advantages of laparoscopy in terms of postoperative morbidity and its superiority for functional recovery, but most of these studies are not fully representative of existing differences within the study population, given the differing policies of patient suitability for the MILS or open approach. The key point of the present study, instead, was to identify a different perspective to deepen the issue of comparison: this need comes from the observation that the period from 2015 to 2017 marked the point during which the number of patients with CLMs treated laparoscopically was equivalent to the number of patients with CLMs treated with an open surgical approach. Since that moment, biases inherent to the achievement of a learning curve and to the establishment of an institutional policy on eligibility for MILS lapsed because patients with more complex conditions, who had previously been excluded from MILS, were instead deemed eligible for laparoscopy. Since 2015, an increase in this trend persisted in favor of the laparoscopic approach. Thus, it was proposed to compare, through a propensity score matching timedependent analysis, patients who had been treated laparoscopically since 2015 with those treated by open surgery before 2015, allowing cases of similar complexity to be compared.
Furthermore, propensity score matching to compare patients undergoing laparoscopic resection and those undergoing open resection during 2015-2017 is not feasible anymore because using the same covariates for propensity score matching-chosen as representative of patient and disease characteristics-reduces the statistical power of the analysis dramatically, thus failing to achieve a good match between the laparoscopic and open groups. This infeasibility resulted in the radical shift in indication toward MILS, resulting in 2 different populations of patients, with no overlap for comparison. Hence, the choice to compare patients who had been treated laparoscopically in 2015-2017 with patients treated with open surgery in a previous period was an attempt to reproduce the same policy of recruitment for each technique and therefore to point out the benefits of laparoscopy. There were 104 patients who underwent MILS and 412 patients who underwent open surgery, in a 1:4 ratio, who were homogeneous for their characteristics and medical complexity, thus conferring enhanced statistical power to the propensity score matching analysis. 14 Improvement in both technological and technical skills is the reason for this increase in the use of laparoscopic procedures. This increase has focused the discussion on 4 cardinal points: feasibility, widening of enrollment criteria, clinical effectiveness, and oncologic outcomes. 
Feasibility
Although the approach to CLMs at the beginning of laparoscopic liver surgery programs was reserved for cases needing minor resections (eg, wedge resections, subsegmentectomies, or resection of laparoscopic segments), the spectrum of possible resections has become wider in recent years; the possibility of laparoscopy has extended to bisegmentectomies, nonlaparoscopic segments (ie, liver segments 1, 4a, 8, and 7), major hepatic resections, and composite and more complex procedures (2-stage hepatectomies, and laparoscopic ALPPS [associating liver partition and portal vein ligation for staged hepatectomy]). Thus, many more procedures for more complex cases are now feasible with laparoscopy, as depicted by Aldrighetti et al 15 in the context of a national registry for laparoscopic liver surgery: among 1678 cases of MILS performed in 48 centers during a 31-month period, CLMs constituted 31.2% of the cases for malignant tumors, thus becoming the second most frequent malignant liver neoplasm after hepatocellular carcinoma to be treated laparoscopically. This wide diffusion is emblematic of how MILS has been adopted in several different clinical settings.
Widening of Enrollment Criteria for MILS
Implementation of technological and technical skills led to the possibility of complete resections with higher grades of complexity, thus developing the concept of parenchymal-sparing resection for CLMs. The further extension of indications arises from the possibility of achieving a positive resection margin (R1), which is considered an acceptable oncologic result for the purpose of parenchymal-sparing resections for CLMs in otherwise unresectable disease. 16 Extension of the laparoscopic approach to CLMs has recently been endorsed by guidelines for laparoscopic liver surgery, 17 confirming that parenchymal-sparing resections should continue to be the basis of treatment of CLMs. Furthermore, in the spectrum of parenchymal-sparing procedures, interventional radiologic procedures associated with laparoscopy offer further extensions. Microwave ablations are now considered as effective as surgical resections for nodules of CLMs up to 2 cm. Nevertheless, the use of thermal ablation for lesions in close proximity to hollow viscous organs (eg, gallbladder, colon, or duodenum) and located on the glissonian surface is contraindicated by the procedure itself. These limitations can often be overcome by the adjunct use of a laparoscopic approach during intraoperative ablative procedures.
Clinical Effectiveness
Since the beginning of its development, laparoscopy has been associated with decreased postoperative morbidity and mortality, key points that have been detected in its role to confer lower 
Limitations
Recurrence of disease was observed in a lower percentage of patients undergoing MILS, although this finding could still be jeopardized by case selection prior to laparoscopy. It can also be speculated that long-term comparative outcomes of MILS and open resections are still hindered by the shorter follow-up time of laparoscopic series, while the effect of a more favorable biological scenario in minimally invasive surgery has yet to be investigated and should be the subject of future targeted investigations. Previous laparoscopic approaches favored repeated resections as the treatment of choice in cases of intrahepatic and extrahepatic recurrence, confirming the superiority of MILS to allow further surgical treatment.
Conclusions
It is expected that an increasing number of patients affected by CLMs will be treated laparoscopically in the future owing to the implementation of the new technology, the parenchymal-sparing techniques of the surgery, and their association with techniques of interventional radiology. Since 2015, an estimated 60% to 70% of patients in the present series have been suitable for a minimally invasive approach. A further increase of 15% to 20% in the future is expected. Nevertheless, there is another 15% to 20% of patients who will never be suitable for laparoscopic surgery owing to exclusion criteria that will always contraindicate minimally invasive surgery. Nevertheless, the four-fifths of patients with metastatic disease treated laparoscopically represents a trend in surgery for CLMs, indicating a more minimally invasive approach in the future. A, Overall survival stratified according to treatment strategy after propensity score matching. B, Disease-free survival stratified according to treatment strategy after propensity score matching.
